Vertex Pharmaceuticals Incorporated (VRTX)
USD 451.61
(-4.85%)
USD 451.61
(-4.85%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4.77 Billion USD | 38.5% |
| 2022 | 3.48 Billion USD | -10.44% |
| 2021 | 3.89 Billion USD | 49.66% |
| 2020 | 2.59 Billion USD | 7.75% |
| 2019 | 2.41 Billion USD | 22.24% |
| 2018 | 1.97 Billion USD | 8.42% |
| 2017 | 1.82 Billion USD | 22.98% |
| 2016 | 1.48 Billion USD | 7.81% |
| 2015 | 1.37 Billion USD | 18.29% |
| 2014 | 1.16 Billion USD | -9.38% |
| 2013 | 1.28 Billion USD | 3.07% |
| 2012 | 1.24 Billion USD | 12.14% |
| 2011 | 1.1 Billion USD | 34.32% |
| 2010 | 825.21 Million USD | 21.36% |
| 2009 | 679.98 Million USD | 9.99% |
| 2008 | 618.2 Million USD | 3.42% |
| 2007 | 597.78 Million USD | 39.16% |
| 2006 | 429.57 Million USD | 46.85% |
| 2005 | 292.53 Million USD | 24.85% |
| 2004 | 234.3 Million USD | -1.85% |
| 2003 | 238.71 Million USD | -5.42% |
| 2002 | 252.4 Million USD | 28.77% |
| 2001 | 196.01 Million USD | 73.88% |
| 2000 | 112.72 Million USD | 7.77% |
| 1999 | 104.6 Million USD | 28.66% |
| 1998 | 81.3 Million USD | 22.07% |
| 1997 | 66.6 Million USD | 43.84% |
| 1996 | 46.3 Million USD | -11.47% |
| 1995 | 52.3 Million USD | 19.41% |
| 1994 | 43.8 Million USD | 43.14% |
| 1993 | 30.6 Million USD | 84.34% |
| 1992 | 16.6 Million USD | 56.6% |
| 1991 | 10.6 Million USD | 65.63% |
| 1990 | 6.4 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.2 Billion USD | 1.49% |
| 2024 Q3 | 1.26 Billion USD | -78.18% |
| 2024 Q2 | 5.78 Billion USD | 378.89% |
| 2023 FY | 4.82 Billion USD | 38.5% |
| 2023 Q1 | 983.7 Million USD | 2.31% |
| 2023 Q2 | 1.04 Billion USD | 6.57% |
| 2023 Q4 | 1.19 Billion USD | 10.91% |
| 2023 Q3 | 1.07 Billion USD | 2.43% |
| 2022 Q2 | 815.4 Million USD | -0.35% |
| 2022 FY | 3.48 Billion USD | -10.44% |
| 2022 Q4 | 961.5 Million USD | 7.82% |
| 2022 Q1 | 818.3 Million USD | -13.82% |
| 2022 Q3 | 891.8 Million USD | 9.37% |
| 2021 Q3 | 691.94 Million USD | -56.8% |
| 2021 FY | 3.89 Billion USD | 49.66% |
| 2021 Q1 | 648.05 Million USD | -4.48% |
| 2021 Q4 | 949.5 Million USD | 37.22% |
| 2021 Q2 | 1.6 Billion USD | 147.17% |
| 2020 Q2 | 612.73 Million USD | -2.86% |
| 2020 Q1 | 630.78 Million USD | -6.59% |
| 2020 FY | 2.59 Billion USD | 7.75% |
| 2020 Q3 | 678.04 Million USD | 10.66% |
| 2020 Q4 | 678.42 Million USD | 0.06% |
| 2019 FY | 2.41 Billion USD | 22.24% |
| 2019 Q3 | 715.62 Million USD | 33.61% |
| 2019 Q2 | 535.59 Million USD | 10.08% |
| 2019 Q4 | 675.28 Million USD | -5.64% |
| 2019 Q1 | 486.53 Million USD | -17.69% |
| 2018 Q1 | 440.36 Million USD | -0.25% |
| 2018 Q2 | 474.83 Million USD | 7.83% |
| 2018 Q3 | 467.8 Million USD | -1.48% |
| 2018 FY | 1.97 Billion USD | 8.42% |
| 2018 Q4 | 591.09 Million USD | 26.35% |
| 2017 Q4 | 441.45 Million USD | -23.31% |
| 2017 Q1 | 386.88 Million USD | 7.96% |
| 2017 Q2 | 416.7 Million USD | 7.71% |
| 2017 FY | 1.82 Billion USD | 22.98% |
| 2017 Q3 | 575.65 Million USD | 38.15% |
| 2016 Q2 | 382.66 Million USD | 5.98% |
| 2016 FY | 1.48 Billion USD | 7.81% |
| 2016 Q4 | 358.36 Million USD | -6.05% |
| 2016 Q3 | 381.42 Million USD | -0.32% |
| 2016 Q1 | 361.07 Million USD | -11.39% |
| 2015 Q2 | 318.25 Million USD | 5.57% |
| 2015 Q4 | 407.48 Million USD | 17.75% |
| 2015 FY | 1.37 Billion USD | 18.29% |
| 2015 Q3 | 346.05 Million USD | 8.74% |
| 2015 Q1 | 301.45 Million USD | 7.67% |
| 2014 Q4 | 279.99 Million USD | 5.19% |
| 2014 FY | 1.16 Billion USD | -9.38% |
| 2014 Q2 | 302.22 Million USD | -3.5% |
| 2014 Q1 | 313.17 Million USD | -3.58% |
| 2014 Q3 | 266.16 Million USD | -11.93% |
| 2013 Q1 | 310.97 Million USD | -3.89% |
| 2013 FY | 1.28 Billion USD | 3.07% |
| 2013 Q4 | 324.79 Million USD | 2.66% |
| 2013 Q2 | 328.97 Million USD | 5.79% |
| 2013 Q3 | 316.37 Million USD | -3.83% |
| 2012 Q1 | 307.51 Million USD | -0.26% |
| 2012 Q2 | 314.05 Million USD | 2.13% |
| 2012 FY | 1.24 Billion USD | 12.14% |
| 2012 Q3 | 297.84 Million USD | -5.16% |
| 2012 Q4 | 323.56 Million USD | 8.63% |
| 2011 Q2 | 270.26 Million USD | 17.44% |
| 2011 Q3 | 299.7 Million USD | 10.89% |
| 2011 Q4 | 308.31 Million USD | 2.87% |
| 2011 FY | 1.1 Billion USD | 34.32% |
| 2011 Q1 | 230.13 Million USD | -0.53% |
| 2010 Q2 | 195.99 Million USD | 9.76% |
| 2010 Q3 | 219.28 Million USD | 11.88% |
| 2010 FY | 825.21 Million USD | 21.36% |
| 2010 Q4 | 231.36 Million USD | 5.51% |
| 2010 Q1 | 178.56 Million USD | 6.41% |
| 2009 Q1 | 172.1 Million USD | 1.94% |
| 2009 Q3 | 168.7 Million USD | -1.83% |
| 2009 Q2 | 171.85 Million USD | -0.14% |
| 2009 FY | 679.98 Million USD | 9.99% |
| 2009 Q4 | 167.8 Million USD | -0.53% |
| 2008 FY | 618.2 Million USD | 3.42% |
| 2008 Q4 | 168.81 Million USD | 7.42% |
| 2008 Q3 | 157.15 Million USD | 0.73% |
| 2008 Q2 | 156.02 Million USD | 14.55% |
| 2008 Q1 | 136.2 Million USD | -1.86% |
| 2007 FY | 597.78 Million USD | 39.16% |
| 2007 Q2 | 159.5 Million USD | 6.97% |
| 2007 Q4 | 138.79 Million USD | -7.7% |
| 2007 Q3 | 150.36 Million USD | -5.73% |
| 2007 Q1 | 149.11 Million USD | 19.31% |
| 2006 FY | 429.57 Million USD | 46.85% |
| 2006 Q1 | 88.08 Million USD | 8.78% |
| 2006 Q4 | 124.98 Million USD | 12.71% |
| 2006 Q3 | 110.88 Million USD | 4.99% |
| 2006 Q2 | 105.62 Million USD | 19.91% |
| 2005 FY | 292.53 Million USD | 24.85% |
| 2005 Q4 | 80.96 Million USD | 8.93% |
| 2005 Q3 | 74.32 Million USD | 5.92% |
| 2005 Q2 | 70.17 Million USD | 4.64% |
| 2005 Q1 | 67.06 Million USD | 1.76% |
| 2004 FY | 234.3 Million USD | -1.85% |
| 2004 Q3 | 59.39 Million USD | 3.09% |
| 2004 Q1 | 51.39 Million USD | -58.18% |
| 2004 Q4 | 65.9 Million USD | 10.97% |
| 2004 Q2 | 57.61 Million USD | 12.09% |
| 2003 Q3 | 59.55 Million USD | -43.3% |
| 2003 Q2 | 105.04 Million USD | 93890.18% |
| 2003 Q4 | 122.9 Million USD | 106.37% |
| 2003 FY | 238.71 Million USD | -5.42% |
| 2003 Q1 | -112 Thousand USD | -100.16% |
| 2002 Q1 | 58.11 Million USD | 5.63% |
| 2002 Q2 | 59.89 Million USD | 3.06% |
| 2002 FY | 252.4 Million USD | 28.77% |
| 2002 Q3 | 63.55 Million USD | 6.1% |
| 2002 Q4 | 70.84 Million USD | 11.48% |
| 2001 Q2 | 37.97 Million USD | 12.96% |
| 2001 Q1 | 33.61 Million USD | 25.7% |
| 2001 FY | 196.01 Million USD | 73.88% |
| 2001 Q4 | 55.01 Million USD | 9.8% |
| 2001 Q3 | 50.1 Million USD | 31.96% |
| 2000 Q1 | 27.18 Million USD | -4.61% |
| 2000 FY | 112.72 Million USD | 7.77% |
| 2000 Q4 | 26.74 Million USD | -11.46% |
| 2000 Q3 | 30.2 Million USD | 5.64% |
| 2000 Q2 | 28.59 Million USD | 5.17% |
| 1999 Q2 | 25.9 Million USD | 1.17% |
| 1999 Q3 | 24.5 Million USD | -5.41% |
| 1999 Q4 | 28.5 Million USD | 16.33% |
| 1999 FY | 104.6 Million USD | 28.66% |
| 1999 Q1 | 25.6 Million USD | 0.79% |
| 1998 Q2 | 17.9 Million USD | 9.15% |
| 1998 FY | 81.3 Million USD | 22.07% |
| 1998 Q1 | 16.4 Million USD | -12.3% |
| 1998 Q3 | 21.6 Million USD | 20.67% |
| 1998 Q4 | 25.4 Million USD | 17.59% |
| 1997 Q1 | 13.3 Million USD | 20.91% |
| 1997 Q2 | 14.2 Million USD | 6.77% |
| 1997 FY | 66.6 Million USD | 43.84% |
| 1997 Q4 | 18.7 Million USD | -7.43% |
| 1997 Q3 | 20.2 Million USD | 42.25% |
| 1996 FY | 46.3 Million USD | -11.47% |
| 1996 Q3 | 11.1 Million USD | -9.76% |
| 1996 Q2 | 12.3 Million USD | 3.36% |
| 1996 Q4 | 11 Million USD | -0.9% |
| 1996 Q1 | 11.9 Million USD | 3.48% |
| 1995 Q1 | 12 Million USD | -0.83% |
| 1995 Q4 | 11.5 Million USD | 1.77% |
| 1995 Q3 | 11.3 Million USD | -35.43% |
| 1995 Q2 | 17.5 Million USD | 45.83% |
| 1995 FY | 52.3 Million USD | 19.41% |
| 1994 Q3 | 11.1 Million USD | 0.0% |
| 1994 FY | 43.8 Million USD | 43.14% |
| 1994 Q1 | 9.7 Million USD | -7.62% |
| 1994 Q2 | 11.1 Million USD | 14.43% |
| 1994 Q4 | 12.1 Million USD | 9.01% |
| 1993 Q4 | 10.5 Million USD | 28.05% |
| 1993 FY | 30.6 Million USD | 84.34% |
| 1993 Q1 | 5.2 Million USD | 13.04% |
| 1993 Q2 | 6.5 Million USD | 25.0% |
| 1993 Q3 | 8.2 Million USD | 26.15% |
| 1992 Q4 | 4.6 Million USD | 6.98% |
| 1992 Q2 | 1.3 Million USD | -63.89% |
| 1992 FY | 16.6 Million USD | 56.6% |
| 1992 Q1 | 3.6 Million USD | 20.0% |
| 1992 Q3 | 4.3 Million USD | 230.77% |
| 1991 FY | 10.6 Million USD | 65.63% |
| 1991 Q1 | - USD | 100.0% |
| 1991 Q3 | 2.6 Million USD | 0.0% |
| 1991 Q2 | 2.6 Million USD | 0.0% |
| 1991 Q4 | 3 Million USD | 15.38% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 FY | 6.4 Million USD | 0.0% |
| 1990 Q4 | -6.4 Million USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbCellera Biologics Inc. | 275.23 Million USD | -1634.9% |
| Alkermes plc | 996.24 Million USD | -379.299% |
| Agenus Inc. | 78.18 Million USD | -6007.466% |
| Aptorum Group Limited | 10.56 Thousand USD | -45192025.686% |
| Ardelyx, Inc. | 169.93 Million USD | -2709.865% |
| Dyadic International, Inc. | 9.15 Million USD | -52070.421% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -21357.781% |
| Lantern Pharma Inc. | 17.87 Million USD | -26609.447% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -70830.477% |
| Novavax, Inc. | 779.12 Million USD | -512.867% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -5790.553% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -5709.285% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -24489.933% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -16028.487% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -8888.001% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -1154.941% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -19544.864% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -12509.258% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -15417.858% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -5536.48% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -27252.924% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -2734.905% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -14495.751% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -2888.353% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | -165.269% |
| AlloVir, Inc. | 180.93 Million USD | -2539.098% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -971.26% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -15987.191% |
| Bicycle Therapeutics plc | 216.92 Million USD | -2101.252% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -2677.745% |
| ChromaDex Corporation | 56.37 Million USD | -8369.466% |
| Chimerix, Inc. | 93.38 Million USD | -5013.022% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -34228.708% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -3071.999% |
| CRISPR Therapeutics AG | 463.49 Million USD | -930.218% |
| Precision BioSciences, Inc. | 92.46 Million USD | -5064.228% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -1779.596% |
| Fortress Biotech, Inc. | 200.19 Million USD | -2285.174% |
| Fortress Biotech, Inc. | 200.19 Million USD | -2285.174% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -14481.934% |
| ImmuCell Corporation | 9.61 Million USD | -49549.79% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -2925.714% |
| Immix Biopharma, Inc. | 16.14 Million USD | -29482.842% |
| Incyte Corporation | 1.19 Billion USD | -301.094% |
| Innoviva, Inc. | 132.15 Million USD | -3513.209% |
| IO Biotech, Inc. | 91.44 Million USD | -5121.832% |
| Jaguar Health, Inc. | 42.01 Million USD | -11264.989% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -2720.82% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -5562.749% |
| ContextLogic Inc. | 387 Million USD | -1133.85% |
| MiMedx Group, Inc. | 229.72 Million USD | -1978.554% |
| MEI Pharma, Inc. | 34.78 Million USD | -13627.181% |
| NextCure, Inc. | 67.63 Million USD | -6959.745% |
| Onconetix, Inc. | 34.9 Million USD | -13579.036% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -37362.733% |
| Opthea Limited | 191.96 Million USD | -2387.402% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -173436.344% |
| Vaxcyte, Inc. | 468.04 Million USD | -920.21% |
| PDS Biotechnology Corporation | 43.04 Million USD | -10992.982% |
| Precigen, Inc. | 84.18 Million USD | -5572.301% |
| Pharming Group N.V. | 225.49 Million USD | -2017.601% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -2745.192% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -6480.217% |
| PureTech Health plc | 144.59 Million USD | -3202.282% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -3565.661% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -1847.724% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -19544.864% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -1988.071% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -15373.606% |
| Acelyrin, Inc. | 422.06 Million USD | -1031.345% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -37032628.401% |
| Summit Therapeutics Inc. | 87.68 Million USD | -5345.567% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -12783.121% |
| Senti Biosciences, Inc. | 94.7 Million USD | -4941.972% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -3764.738% |
| Elevation Oncology, Inc. | 45.44 Million USD | -10407.207% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -16103.468% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -121029.93% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -3512.635% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -13909.095% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -56402.189% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -2533.742% |
| Seer, Inc. | 110.49 Million USD | -4221.658% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -6664.031% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -5008.154% |
| ESSA Pharma Inc. | 32.13 Million USD | -14759.602% |
| GlycoMimetics, Inc. | 39.28 Million USD | -12054.676% |
| GT Biopharma, Inc. | 13.57 Million USD | -35072.363% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -2072.133% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -2274.263% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -1740.609% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -8312.763% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -8729.512% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -47949.613% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | -1083.211% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -25125.844% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -9319.446% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -1738.95% |
| Aptose Biosciences Inc. | 52.35 Million USD | -9020.254% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -33035.851% |
| Soligenix, Inc. | 7.79 Million USD | -61155.244% |
| Century Therapeutics, Inc. | 56.07 Million USD | -8415.989% |
| Kura Oncology, Inc. | 165.8 Million USD | -2779.906% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -4070.051% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -57298.726% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -192313.159% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -4333.694% |
| Autolus Therapeutics plc | 196.72 Million USD | -2327.234% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -5540.408% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -4000.367% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -24534.989% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -1384.035% |
| GRI Bio, Inc. | 11.33 Million USD | -42044.748% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -67575.77% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -3539.676% |
| IGM Biosciences, Inc. | 265.59 Million USD | -1697.877% |
| INmune Bio, Inc. | 29.89 Million USD | -15872.036% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -2667.25% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -11744.429% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -29782.296% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -30233.729% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -7589.459% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -4340.952% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -1631.999% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -1484.005% |
| Verastem, Inc. | 92.08 Million USD | -5085.483% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -26517.982% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -2471.006% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -3833.052% |
| Histogen Inc. | 14.27 Million USD | -33357.119% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -29654.223% |
| Surrozen, Inc. | 18.55 Million USD | -25641.24% |
| Organovo Holdings, Inc. | 14.91 Million USD | -31914.75% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -93707.045% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -7901.923% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -18518.162% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -10058.278% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -62458.604% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -2580.536% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -9755.937% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -1848.948% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -30973.94% |
| Apollomics, Inc. | 54.14 Million USD | -8719.727% |
| Amarin Corporation plc | 272.35 Million USD | -1653.214% |
| Mesoblast Limited | 5.9 Million USD | -80804.778% |
| Turnstone Biologics Corp. | 78.33 Million USD | -5995.382% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -1855.989% |
| Synaptogenix, Inc. | 8.31 Million USD | -57334.254% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -32636.871% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -1786.934% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -14226.4% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -53969.448% |
| Exelixis, Inc. | 1.58 Billion USD | -200.925% |
| Better Therapeutics, Inc. | 38.26 Million USD | -12379.745% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -1957.746% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | -458.348% |
| NLS Pharmaceutics AG | 11.8 Million USD | -40341.895% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -59276.471% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -15820.381% |
| Gritstone bio, Inc. | 148.37 Million USD | -3118.219% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -6834.259% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -29086.653% |
| Avid Bioservices, Inc. | 25.99 Million USD | -18268.21% |
| Insmed Incorporated | 949.26 Million USD | -403.023% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -30333.808% |
| MediWound Ltd. | 18.86 Million USD | -25207.399% |
| OmniAb, Inc. | 83.89 Million USD | -5591.638% |
| Alector, Inc. | 248.8 Million USD | -1819.197% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -1937.916% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -9038.581% |
| Zai Lab Limited | 547.47 Million USD | -772.184% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -1097.781% |
| Aura Biosciences, Inc. | 84.99 Million USD | -5518.242% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -1832.119% |
| Immunic, Inc. | 99.22 Million USD | -4712.392% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -2902.918% |
| Veracyte, Inc. | 357.93 Million USD | -1234.049% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 47.037% |
| FibroGen, Inc. | 398.11 Million USD | -1099.408% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -33503.096% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -69223.995% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -66910.659% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | -46.669% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -18355.533% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -1408.484% |
| TG Therapeutics, Inc. | 198.47 Million USD | -2305.845% |
| Galecto, Inc. | 35.62 Million USD | -13302.756% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -11635.358% |
| Fortrea Holdings Inc. | 457.3 Million USD | -944.172% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -8697.303% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -16435.079% |
| XBiotech Inc. | 37.51 Million USD | -12629.939% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -6834.259% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -23024.607% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -3261.232% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -4719.581% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -4212.836% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | -398.305% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -16453.995% |
| Vaxxinity, Inc. | 56.05 Million USD | -8419.027% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -1008.815% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -21304.577% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -4206.962% |
| NexImmune, Inc. | 28.16 Million USD | -16852.155% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -86232.397% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -26587.143% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | -69.609% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -18655.646% |
| Scopus BioPharma Inc. | 11.71 Million USD | -40660.138% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -3658.008% |
| Ainos, Inc. | 12.95 Million USD | -36765.006% |
| Pluri Inc. | 22.48 Million USD | -21141.103% |
| Prothena Corporation plc | 282.4 Million USD | -1590.828% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -2287.237% |
| Celularity Inc. | 215.05 Million USD | -2120.331% |
| Rallybio Corporation | 78.93 Million USD | -5949.511% |
| Cue Biopharma, Inc. | 19.54 Million USD | -24334.551% |
| MeiraGTx Holdings plc | 151.07 Million USD | -3060.619% |
| Omeros Corporation | 94.75 Million USD | -4939.525% |
| Humacyte, Inc. | 23.49 Million USD | -20221.743% |
| Immunocore Holdings plc | 308.04 Million USD | -1450.123% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -140755.457% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -5397.036% |
| Blueprint Medicines Corporation | 722.86 Million USD | -560.57% |
| CalciMedica, Inc. | 21.81 Million USD | -21786.602% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -6295.66% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -2874.337% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -2687.589% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -1518.973% |
| Pulmatrix, Inc. | 22.03 Million USD | -21567.12% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -13710.557% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -5273.259% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -765.717% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -6481.577% |
| Cytokinetics, Incorporated | 173.61 Million USD | -2650.386% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -13773.151% |
| Nutriband Inc. | 5.73 Million USD | -83174.75% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -10848.57% |
| Vor Biopharma Inc. | 126.03 Million USD | -3688.6% |
| Roivant Sciences Ltd. | 1.18 Billion USD | -301.538% |
| Evogene Ltd. | 27.79 Million USD | -17082.44% |
| ProKidney Corp. | 151.52 Million USD | -3051.358% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -6337.479% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -61975.53% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -677.4% |
| CorMedix Inc. | 48.95 Million USD | -9653.3% |
| BioLineRx Ltd. | 50.8 Million USD | -9299.236% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -3068.547% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -12442.026% |
| Atai Life Sciences N.V. | 125.78 Million USD | -3696.16% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -5748.899% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -5765.445% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -1790.7% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -14484.606% |
| MediciNova, Inc. | 10.9 Million USD | -43706.274% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -3606.723% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -65675.662% |
| GeoVax Labs, Inc. | 6.02 Million USD | -79190.316% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -902.393% |
| Biomea Fusion, Inc. | 126.13 Million USD | -3685.627% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | -263.993% |
| Mereo BioPharma Group plc | 35.84 Million USD | -13222.359% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -2398.836% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -1976.502% |
| Absci Corporation | 73.66 Million USD | -6381.959% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -17212.015% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -3474.369% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -1871.821% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -1722.185% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -2195.739% |
| Allakos Inc. | 196.05 Million USD | -2335.529% |
| Imunon, Inc. | 20.31 Million USD | -23410.094% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -4108.198% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -1195.4% |
| BioAtla, Inc. | 129.68 Million USD | -3581.942% |
| NLS Pharmaceutics AG | 11.8 Million USD | -40341.895% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -30039.494% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -5523.072% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -11334.935% |
| XOMA Corporation | 46.46 Million USD | -10176.995% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -4195.185% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -3251.747% |
| aTyr Pharma, Inc. | 12.97 Million USD | -36690.2% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -4506.583% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -2662.191% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -1774.284% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -12664.649% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -57956.024% |
| Akari Therapeutics, Plc | 16.8 Million USD | -28312.472% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -209885.18% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -1495.293% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -70864.357% |
| UroGen Pharma Ltd. | 138.88 Million USD | -3338.022% |
| Sutro Biopharma, Inc. | 243 Million USD | -1864.948% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -65539.149% |
| Orgenesis Inc. | 45.75 Million USD | -10335.562% |
| Entera Bio Ltd. | 8.86 Million USD | -53793.905% |
| GH Research PLC | 41.22 Million USD | -11483.62% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -18473.985% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -5649.341% |
| Xencor, Inc. | 306.97 Million USD | -1455.491% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -96685.191% |
| Replimune Group, Inc. | 234.77 Million USD | -1933.88% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -23204.178% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -2389.624% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -70864.357% |
| Portage Biotech Inc. | 18.19 Million USD | -26137.705% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -65675.662% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -4449.309% |
| OncoCyte Corporation | 25.63 Million USD | -18525.424% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -78235.103% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -41577.355% |
| Purple Biotech Ltd. | -22.46 Million USD | 21353.394% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -28874.515% |
| scPharmaceuticals Inc. | 65.17 Million USD | -7226.092% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -56390.585% |
| HilleVax, Inc. | 133.34 Million USD | -3480.937% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -46326.835% |
| Tharimmune, Inc. | 9.45 Million USD | -50401.205% |
| Genprex, Inc. | 31.06 Million USD | -15273.191% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -2446.314% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -15118.153% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -624083.007% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -87564.237% |
| OKYO Pharma Limited | 8243.57 USD | -57923833.441% |
| Savara Inc. | 15.74 Million USD | -30227.088% |
| Curis, Inc. | 58.35 Million USD | -8082.675% |
| Daré Bioscience, Inc. | 33.6 Million USD | -14107.334% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -93665.562% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -63899.464% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -17570.787% |
| BeiGene, Ltd. | 3.28 Billion USD | -45.287% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -23847.681% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -857.365% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -3007.672% |
| Erasca, Inc. | 141.52 Million USD | -3273.962% |
| bluebird bio, Inc. | 240.23 Million USD | -1887.662% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -105378.847% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | -173.439% |
| DBV Technologies S.A. | 92.16 Million USD | -5081.207% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -105378.847% |
| Moderna, Inc. | 6.39 Billion USD | 25.321% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -11106.553% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -33138.201% |
| Molecular Templates, Inc. | 63.09 Million USD | -7468.433% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -7058.813% |
| Travere Therapeutics, Inc. | 472 Million USD | -911.648% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -3231.915% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -7591.44% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -10898.756% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -2194.239% |
| MacroGenics, Inc. | 217.21 Million USD | -2098.283% |
| RenovoRx, Inc. | 11.39 Million USD | -41800.667% |
| Adicet Bio, Inc. | 152.03 Million USD | -3040.662% |
| Prime Medicine, Inc. | 186.63 Million USD | -2458.415% |
| Aditxt, Inc. | 25.95 Million USD | -18300.228% |
| Adagene Inc. | 41.83 Million USD | -11314.882% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -65220.602% |
| Quantum-Si incorporated | 111.65 Million USD | -4176.413% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -2678.586% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -32655.357% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -13229.797% |
| SciSparc Ltd. | 9.01 Million USD | -52890.789% |
| Vericel Corporation | 142.04 Million USD | -3261.729% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -55059.817% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -20581.207% |
| Generation Bio Co. | 144.46 Million USD | -3205.253% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -5650.933% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -5422.785% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -1514.703% |
| Invivyd, Inc. | 205.75 Million USD | -2220.721% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -6517.331% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -50814.304% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -6245.178% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -46317.809% |
| 2seventy bio, Inc. | 289.88 Million USD | -1547.194% |
| ADMA Biologics, Inc. | 66.58 Million USD | -7071.177% |
| Clene Inc. | 41.07 Million USD | -11525.642% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -37181.718% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -8614.14% |
| GeoVax Labs, Inc. | 6.02 Million USD | -79190.316% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -1256.349% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -12899.558% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -14057.377% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -4504.54% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -14552.183% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -2704.238% |
| Vir Biotechnology, Inc. | 767.72 Million USD | -521.972% |
| Evaxion Biotech A/S | 22.27 Million USD | -21341.401% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -3422.841% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -1932.936% |
| Trevena, Inc. | 38.41 Million USD | -12330.688% |
| Surrozen, Inc. | 18.55 Million USD | -25641.24% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -5872.856% |
| Cingulate Inc. | 22.75 Million USD | -20880.537% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 63834.65% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -10590.219% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -57891.671% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -4555.902% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | -533.218% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -7592.432% |
| Clearmind Medicine Inc. | 8.74 Million USD | -54525.43% |
| Kronos Bio, Inc. | 128.11 Million USD | -3627.033% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -5579.656% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -162703.424% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -4635.835% |
| Statera Biopharma, Inc. | 28.82 Million USD | -16462.892% |
| ImmunityBio, Inc. | 362.87 Million USD | -1215.891% |
| Korro Bio, Inc. | 84.53 Million USD | -5548.615% |
| Kineta, Inc. | 21.15 Million USD | -22470.429% |
| BioVie Inc. | 31.95 Million USD | -14845.13% |
| Codexis, Inc. | 66.51 Million USD | -7078.508% |
| Celularity Inc. | 215.05 Million USD | -2120.331% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -2007.042% |
| Celcuity Inc. | 66.23 Million USD | -7109.688% |
| Virax Biolabs Group Limited | 6.54 Million USD | -72833.467% |
| Cibus, Inc. | 320.3 Million USD | -1390.767% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -11004.651% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -14008.852% |
| IN8bio, Inc. | 30.33 Million USD | -15639.856% |
| Kodiak Sciences Inc. | 277.32 Million USD | -1621.831% |
| Annexon, Inc. | 143.72 Million USD | -3222.363% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -3642.427% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -20743.337% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -745993.75% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | -512.504% |
| Eyenovia, Inc. | 25.4 Million USD | -18694.443% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -3303.057% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -85750.414% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -5934.145% |
| Arcellx, Inc. | 200.19 Million USD | -2285.127% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -10303.05% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -2106.45% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -47856.212% |
| Moolec Science SA | 52.75 Million USD | -8952.029% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -7710.2% |
| Geron Corporation | 70.44 Million USD | -6678.723% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -10159.991% |
| Royalty Pharma plc | 862.4 Million USD | -453.685% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -4975.899% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -51090.701% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -21001.677% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -2197.75% |
| Humacyte, Inc. | 23.49 Million USD | -20221.743% |
| Structure Therapeutics Inc. | 102.77 Million USD | -4546.072% |
| 89bio, Inc. | 151.2 Million USD | -3057.985% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -5858.918% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -32740.44% |
| Genelux Corporation | 24.33 Million USD | -19521.944% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -13975.996% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -2662.207% |
| Notable Labs, Ltd. | 14.77 Million USD | -32229.045% |
| Liquidia Corporation | 87.98 Million USD | -5327.123% |
| Mustang Bio, Inc. | 48.5 Million USD | -9745.158% |
| Immunovant, Inc. | 282.7 Million USD | -1589.016% |
| Quantum-Si incorporated | 111.65 Million USD | -4176.413% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -21080.802% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -22352.626% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -4580.822% |
| Acasti Pharma Inc. | 11.3 Million USD | -42152.898% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -20732.329% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -29782.296% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -10159.551% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -420760.583% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -29957.913% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -16276.856% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -11438.276% |
| PepGen Inc. | 84.76 Million USD | -5533.155% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -16014.88% |
| United Therapeutics Corporation | 885.1 Million USD | -439.487% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -20754.26% |
| Solid Biosciences Inc. | 104.31 Million USD | -4477.482% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -14491.053% |
| Immuneering Corporation | 58.41 Million USD | -8074.566% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -93707.045% |
| Silo Pharma, Inc. | 3.92 Million USD | -121653.578% |
| Belite Bio, Inc | 31.66 Million USD | -14978.312% |
| XOMA Corporation | 46.46 Million USD | -10176.995% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -6968.838% |
| Bionomics Limited | 17.89 Billion USD | 73.313% |
| Apogee Therapeutics, Inc. | 93 Million USD | -5034.243% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 13482.848% |
| uniQure N.V. | 285.08 Million USD | -1574.933% |
| Cassava Sciences, Inc. | 105.95 Million USD | -4406.545% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -65220.602% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -2358.717% |
| Forte Biosciences, Inc. | 32.47 Million USD | -14602.713% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -57369.501% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -16144.259% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -85750.414% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -33503.096% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -53618.079% |
| Altimmune, Inc. | 30.55 Million USD | -15527.045% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -1016.565% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 13482.848% |
| Compugen Ltd. | 43.97 Million USD | -10759.43% |
| Peak Bio, Inc. | 1249.13 USD | -382265957.176% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -6342.256% |
| Benitec Biopharma Inc. | 22.38 Million USD | -21234.108% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -1863.493% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -16629.145% |
| Zura Bio Limited | 62.63 Million USD | -7523.168% |
| PolyPid Ltd. | 21.04 Million USD | -22589.475% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -29237.675% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -16629.145% |
| Instil Bio, Inc. | 85.78 Million USD | -5466.241% |
| argenx SE | 1.53 Billion USD | -211.373% |
| Immunome, Inc. | 122.82 Million USD | -3787.803% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -9750.845% |
| Verona Pharma plc | 67.15 Million USD | -7010.81% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -18346.977% |
| Shattuck Labs, Inc. | 93.61 Million USD | -5000.733% |
| CervoMed Inc. | 14.95 Million USD | -31823.214% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -6653.603% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -55787.172% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -9262.745% |
| Moolec Science SA | 52.75 Million USD | -8952.029% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -28930.109% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -3502.275% |
| AnaptysBio, Inc. | 181.56 Million USD | -2529.869% |
| Design Therapeutics, Inc. | 78.19 Million USD | -6006.919% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -5385.92% |
| NeurAxis, Inc. | 8.82 Million USD | -54030.963% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -37841.994% |
| Lumos Pharma, Inc. | 38.66 Million USD | -12249.67% |
| Achilles Therapeutics plc | 75.25 Million USD | -6245.093% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -18346.977% |
| 180 Life Sciences Corp. | 13.47 Million USD | -35329.419% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -17917.208% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -162703.424% |
| Nutriband Inc. | 5.73 Million USD | -83174.75% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -4210.345% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -8479.951% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -9285.011% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -7124.012% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -8722.481% |
| Palisade Bio, Inc. | 13.32 Million USD | -35748.348% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -10415.537% |
| Beam Therapeutics Inc. | 554.19 Million USD | -761.612% |
| Neurogene Inc. | 55.58 Million USD | -8490.756% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -1821.614% |
| AEON Biopharma, Inc. | 48.42 Million USD | -9759.795% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -4837.442% |
| Sesen Bio, Inc. | 78.38 Million USD | -5992.038% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -5616.577% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -37836.279% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -958.775% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -5332.928% |
| Athira Pharma, Inc. | 125.46 Million USD | -3705.812% |
| Vaccinex, Inc. | 23.45 Million USD | -20258.133% |
| HCW Biologics Inc. | 21.02 Million USD | -22608.337% |
| XOMA Corporation | 46.46 Million USD | -10176.995% |
| Nektar Therapeutics | 190.9 Million USD | -2401.27% |
| Arvinas, Inc. | 480 Million USD | -894.792% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -209885.18% |
| Merus N.V. | 200.49 Million USD | -2281.617% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -4519.999% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -13692.605% |
| Rezolute, Inc. | 70.38 Million USD | -6683.923% |
| Clene Inc. | 41.07 Million USD | -11525.642% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -29054.12% |
| BeyondSpring Inc. | 24.86 Million USD | -19103.7% |
| Synlogic, Inc. | 58.53 Million USD | -8057.931% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -26587.905% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -106200.089% |
| Peak Bio, Inc. | 1249.13 USD | -382265957.176% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -7799.613% |
| Krystal Biotech, Inc. | 160.42 Million USD | -2876.45% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -1664.395% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -1271.977% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -221299.579% |
| MannKind Corporation | 125.59 Million USD | -3701.842% |
| Ikena Oncology, Inc. | 84.57 Million USD | -5545.743% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -49397.253% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -5229.182% |
| Gossamer Bio, Inc. | 183.75 Million USD | -2498.512% |
| CohBar, Inc. | 12.38 Million USD | -38444.442% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -9313.69% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -17212.015% |
| Legend Biotech Corporation | 583.14 Million USD | -718.836% |
| Mural Oncology plc | 192.07 Million USD | -2386.06% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -7011.263% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -29475.224% |
| Disc Medicine, Inc. | 91.12 Million USD | -5140.055% |
| Champions Oncology, Inc. | 28.11 Million USD | -16886.837% |
| REGENXBIO Inc. | 321.15 Million USD | -1386.812% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -88965.316% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -8464.101% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -12155.958% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -4075.521% |
| Vaxart, Inc. | 90.72 Million USD | -5163.1% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -55944.548% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -11058.085% |
| Cellectis S.A. | 97.32 Million USD | -4806.494% |
| Longeveron Inc. | 21.25 Million USD | -22370.588% |
| Repare Therapeutics Inc. | 167.35 Million USD | -2753.182% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | -250.892% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -6212.38% |
| Revolution Medicines, Inc. | 498.76 Million USD | -857.365% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -71682.922% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -10763.63% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -6301.662% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -6757.184% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -43073.599% |
| Denali Therapeutics Inc. | 527.23 Million USD | -805.677% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -55059.817% |
| Veru Inc. | 101.34 Million USD | -4611.482% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -20299.88% |
| Cingulate Inc. | 22.75 Million USD | -20880.537% |
| Passage Bio, Inc. | 108.38 Million USD | -4305.429% |
| Context Therapeutics Inc. | 25.07 Million USD | -18944.682% |
| Exicure, Inc. | 14.07 Million USD | -33822.989% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -2217.241% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -10927.459% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -51930.61% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -1791.216% |
| Nuvalent, Inc. | 149.49 Million USD | -3094.151% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -59092.488% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -4506.85% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -22162.11% |
| OmniAb, Inc. | 83.89 Million USD | -5591.638% |
| Anew Medical, Inc. | 1.3 Million USD | -366970.226% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -14473.923% |
| Lipocine Inc. | 15.08 Million USD | -31564.164% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -6869.48% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -6170.354% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -11744.429% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -4057.85% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -21232.202% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -618.97% |
| Ocugen, Inc. | 71.56 Million USD | -6572.07% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -4987.039% |
| Q32 Bio Inc. | 92.68 Million USD | -5052.136% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -22451.242% |
| Alumis Inc. Common Stock | 158.17 Million USD | -2918.827% |
| Equillium, Inc. | 50.6 Million USD | -9335.64% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -7551.508% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -34238.795% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -25211.278% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -10070.177% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -4302.301% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -38430.664% |
| Dominari Holdings Inc. | 23.83 Million USD | -19933.564% |
| Edesa Biotech, Inc. | 9.22 Million USD | -51674.101% |
| vTv Therapeutics Inc. | 11.9 Million USD | -40002.461% |
| Bio-Techne Corporation | 563.03 Million USD | -748.076% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -1068.036% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -1676.705% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -3509.849% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -33034.411% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -2816.992% |
| Nkarta, Inc. | 131.65 Million USD | -3527.041% |
| BioCardia, Inc. | 12.12 Million USD | -39294.439% |
| Iterum Therapeutics plc | 47.46 Million USD | -9959.408% |